Bayesian enhancement two‐stage design for single‐arm phase II clinical trials with binary and time‐to‐event endpoints (Q4628377)
From MaRDI portal
 | This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use this page instead for the normal view: Bayesian enhancement two‐stage design for single‐arm phase II clinical trials with binary and time‐to‐event endpoints |
scientific article; zbMATH DE number 7035512
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Bayesian enhancement two‐stage design for single‐arm phase II clinical trials with binary and time‐to‐event endpoints |
scientific article; zbMATH DE number 7035512 |
Statements
Bayesian enhancement two‐stage design for single‐arm phase II clinical trials with binary and time‐to‐event endpoints (English)
0 references
13 March 2019
0 references
Bayesian adaptive design
0 references
highest posterior density interval
0 references
phase II clinical trial
0 references
posterior probability
0 references
Simon's design
0 references
survival endpoint
0 references
